Aug 3, 2026 | Biosimilars, Cost Savings, Drug costs, Pharmacy, Prescription, Rx Costs, Savings, Specialty Drugs
Specialty drug costs are projected to jump another 32% by 2028, according to the Pharmacy Strategies Group. While greater utilization remains the primary driver, lower-cost biosimilars can help pharmacy plans offset the increase. Biosimilars’ overall market share...
May 4, 2026 | Biosimilars, Cost Savings, Drug costs, MedBen Rx, Rebates, Rx Costs, Savings
Specialty drugs account for more than half of total drug spend and are often the largest cost driver for employer pharmacy plans. A recent BenefitPRO article points to biosimilars as a practical solution — and for MedBen Rx clients, the effect is already clear, with...
May 1, 2026 | Cost Savings, Forensic claims review, Fraud Control Unit, Medicaid, Recovery Audit Contractor (RAC), Savings
In the federal government’s latest push against Medicaid fraud and waste, the Trump administration will require all 50 states to submit plans outlining how they will revalidate high-risk providers. This heightened focus on accountability mirrors MedBen’s ongoing...
Feb 23, 2026 | Biosimilars, Cost Savings, Drug costs, MedBen Rx, Rx Costs, Specialty Drugs
Specialty medications continue to dominate pharmacy spend, now accounting for 52% of all U.S. pharmaceutical sales, according to a recent report from the Healthcare Distribution Alliance. With costs often reaching tens — or even hundreds — of thousands of dollars per...
Jan 27, 2026 | Announcements, Claims, Claims Management, Cost Savings, Discounts, Forensic claims review, MedBen News, Preferred provider organization (PPO), Savings
$22.38 per employee per monthThat’s the average savings MedBen clients realized in 2025 through forensic claims review — the largest annual per-employee impact since the service launched in 2007. Savings like these don’t happen by accident — or by auto-adjudication....
Dec 2, 2025 | Alternative Reimbursement Strategies, Cost management, Cost Savings, Direct-to-Employer Contracting, Drug costs, Fair Market Pricing, Forensic claims review, Health care costs, High-cost claims, MedBen Analytics, MedBen Rx, MedBen WellLiving, Rx Costs, Self-funding, Survey
As 2026 approaches, employers and employees alike are seeking greater stability in how they pay for health care. While national costs continue to rise, self-funding give employers a level of control over spending and plan design that traditional coverages often lack....
